Gregory P. Botta - Concepedia

Author

Gregory P. Botta

University of California San Diego ORCID

Also Known As

, G. Botta, Gregory Botta, Gregory P Botta, Gregory P. Botta

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Drexel University Moores Cancer Center Medical College of Wisconsin Natera (United States)

About

Gregory P. Botta is an author at University of California San Diego specializing in medicine, cancer research, and molecular oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	190
2	Engineering	2	2	427
3	Biomedical Engineering	2	2	427
4	Health Sciences	1	1	21
5	Cell Biology	1	1	101

Gregory P. Botta

Publications

Citations

H-Index

Page 1

	Year	Citations
Electrospun hydroxyapatite-containing chitosan nanofibers crosslinked with genipin for bone tissue engineering Michael Frohbergh, Anna Katsman, Gregory P. Botta, Biomaterials Tissue EngineeringRegenerative MedicineNanofiberSynthetic Bone SubstituteEngineering	2012	400
Isolation, culture and genetic manipulation of mouse pancreatic ductal cells Maximilian Reichert, Shigetsugu Takano, Steffen Heeg, Nature Protocols Knockout MouseDevelopmental BiologyPancreatic CancerMedicineGenetic Manipulation	2013	101
Tumor-penetrating therapy for β5 integrin-rich pancreas cancer Tatiana Hurtado de Mendoza, Evangeline Mose, Gregory P. Botta, Nature Communications	2021	80
SWI/SNF complex alterations as a biomarker of immunotherapy efficacy in pancreatic cancer Gregory P. Botta, Shumei Kato, Hitendra Patel, JCI Insight	2021	66
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers Brandon M. Huffman, Vasily N. Aushev, Griffin Budde, JCO Precision Oncology	2022	63
Constitutive <i>K</i> - <i>Ras</i> G12D Activation of ERK2 Specifically Regulates 3D Invasion of Human Pancreatic Cancer Cells via MMP-1 Gregory P. Botta, Mauricio J. Reginato, Maximilian Reichert, Molecular Cancer Research	2011	44
Multicenter phase Ib trial in the U.S. of salvage CT041 CLDN18.2-specific chimeric antigen receptor T-cell therapy for patients with advanced gastric and pancreatic adenocarcinoma. Gregory P. Botta, Carlos Becerra, Zhaohui Jin, Journal of Clinical Oncology ImmunologyPathologyAdvanced GastricImmunotherapyPrimary Gastric	2022	29
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma Gregory P. Botta, Maen Abdelrahim, Ronald Drengler, The Oncologist	2024	29
Real-time assessment of three-dimensional cell aggregation in rotating wall vessel bioreactors in vitro Gregory P. Botta, Prakash Manley, Steven C. Miller, Nature Protocols MechanobiologyTissue EngineeringVascular Tissue EngineeringEngineeringBioengineering Model	2006	27
Personalized matched targeted therapy in advanced pancreatic cancer: a pilot cohort analysis Justin Shaya, Shumei Kato, Jacob J. Adashek, npj Genomic Medicine	2023	26

Page 1